---
figid: PMC10380530__ijms-24-11547-g001
pmcid: PMC10380530
image_filename: ijms-24-11547-g001.jpg
figure_link: /pmc/articles/PMC10380530/figure/ijms-24-11547-f001/
number: Figure 1
figure_title: ''
caption: 'Mechanism of the IL-1β pathway and its downstream effects. Legend: GSDMD—gasdermin
  D; IRAK—IL-1 receptor-associated kinase; MYD88—myeloid differentiation primary response
  88; TRAF6—tumor necrosis factor receptor associated factor 6; MAPK—mitogen-activated
  protein kinase; IkB—inhibitor of nuclear factor kappa B; NF-kB (nuclear factor kappa
  B); AP-1—activator protein 1.'
article_title: 'Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and
  PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management.'
citation: Dani Ran Castillo, et al. Int J Mol Sci. 2023 Jul;24(14):11547.
year: '2023'

doi: 10.3390/ijms241411547
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- interleukin-1 beta (IL-1β)
- immune-checkpoint inhibitors (ICIs)
- non-small cell lung cancer (NSCLC)
- programmed death ligand 1 (PD-L1)
- therapeutic resistance

---
